The National Institutes of Health is offering a grant to develop and evaluate loyalty/reward-based digital technologies as a combination product to improve medication adherence in substance use disorder treatment. Phase I focuses on establishing feasibility, while Phase 2 evaluates efficacy in a larger sample by incentivizing adherence to FDA-approved medications. The technologies should provide automated tracking, real-time assessments, and patient progress monitoring for treatment providers. Data gathered will support a 510k submission for FDA clearance. Closing date for applications is Dec 14, 2018. (Clinical Trial Optional)
Opportunity ID: 309080
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-19-015 |
Funding Opportunity Title: | Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Pharmacotherapies (R41/R42 – Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 19, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | Dec 14, 2018 |
Current Closing Date for Applications: | Dec 14, 2018 |
Archive Date: | Jan 19, 2019 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement is to develop and evaluate the loyalty/reward-based digital technologies (e.g., mobile medical app/device platforms and other digital technologies) to be used as a combination product to increase medication adherence. The objective of Phase I (R41) is to establish the feasibility and/or validation of the device, and Phase 2 is designed to test the efficacy of the reward-based platform in a larger sample. The primary endpoint is adherence to FDA-approved medications for substance use disorders. Rewards and contingencies should be delivered in a self-sustaining manner and include a front-end interface allowing treatment providers to monitor progress and deliver rewards. Platforms may include novel features including, but not limited to, automated tracking tools, real-time assessments of patient progress, medication intake, and momentary assessment. Data generated from these studies are to be used to support a 510k submission to seek clearance as an FDA cleared device. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-015.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | FORMS-E | PKG00244998 | Nov 14, 2018 | Dec 14, 2018 | View |
Package 1
Mandatory forms
309080 RR_SF424_2_0-2.0.pdf
309080 PHS398_CoverPageSupplement_4_0-4.0.pdf
309080 RR_OtherProjectInfo_1_4-1.4.pdf
309080 PerformanceSite_2_0-2.0.pdf
309080 RR_KeyPersonExpanded_2_0-2.0.pdf
309080 RR_Budget_1_4-1.4.pdf
309080 RR_SubawardBudget30_1_4-1.4.pdf
309080 PHS398_ResearchPlan_4_0-4.0.pdf
309080 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
309080 PHS_AssignmentRequestForm_2_0-2.0.pdf